Mean female age at first birth has increased steadily over the past few decades in many developed countries. This postponement leads to couples attempting to have children during a period where female fertility is already in decline.
Anti-Müllerian hormone (AMH)
AMH is a direct serum marker of functional ovarian reserve and plays an important role in assessing ovarian reserve levels.1,2
AMH is a reliable marker for the assessment of the ovarian reserve in conjunction with other clinical and laboratory findings before starting any fertility therapy. AMH adds prognostic information to the counseling and planning process for infertile couples seeking fertility treatment.
- Fully automated, fast, sensitive and robust measurement of AMH3
- High precision over entire measuring range for reliable results3
- Clinical agreement with Antral-Follicle-Count (AFC)4
- Age specific reference ranges.